Skip to content

AARD AARD Retained Earnings

Retained Earnings at other companies

AbbVie logo
AbbVieABBV
-$17.87B-87.6%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
-$717.32M-8.9%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-$1.41B-16.8%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-$455.06M-17.8%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$1.01B-88.5%
Arvinas logo
ArvinasARVN
-$1.67B-15.3%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's retained earnings?
AARD (AARD) reported retained earnings of -$137.51M in Q1 2026.
How has AARD's retained earnings changed year-over-year?
AARD's retained earnings decreased by 103.3% year-over-year, from -$67.64M to -$137.51M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.